Results 201 to 210 of about 6,578,993 (340)

Unusual Cutaneous and Lymphatic Findings in an Adult Patient

JEADV Clinical Practice, EarlyView.
Sarah Preis, Mara Hubbuch, Susanne Annette Steimle‐Grauer, Tilo Biedermann, Oana‐Diana Persa   +4 more
wiley   +1 more source

Novel Bispecific Engagers Targeting the CεmX Domain of mIgE‐Expressing Cells

Allergy, EarlyView.
We developed bispecific TCE & NKCE targeting the CεmX domain of mIgE to eliminate IgE‐producing cells. Both constructs demonstrated potent, specific, dose‐dependent cytotoxicity and selective immune activation in vitro. These results highlight their promise as off‐the‐shelf, potentially curative therapeutics for IgE‐associated allergic diseases ...
Constantin Möller, Julia Hambach, Alessa Zoe Schaffrath, Thomas Eden, Sophia Cichutek, Anna Josephine Gebhardt, Natalie Tode, Ronald Maitschke‐Rajasekharan, Philipp Lewe, Sharon Qi, Susanne Witt, Marie Eggers, Nicola M. Tomas, Friedrich Haag, Friedrich Koch‐Nolte, Boris Fehse, Kristoffer Riecken   +16 more
wiley   +1 more source

Real-world drug regimes for multiple myeloma in a Swiss population (2012 to 2017) : cost-outcome description [PDF]

, 2019
Blozik, Eva, Eichler, Klaus, Rapold, Ronald, Reich, Oliver, Wieser, Simon   +4 more
core   +1 more source

Bortezomib-Induced Myocarditis in a Patient With Multiple Myeloma. [PDF]

JACC Case Rep
Domínguez-Linares A, Nieto-Dolores AK, Garcia-Cardenas M, Gonzalez-Trejo A, Ayala-Bustamante E, Valencia-Hernandez HA, Viñas-Mendieta A, Ruiz-Mori E, Espinola-Zavaleta N.   +8 more
europepmc   +1 more source

High-dose chemotherapy with hematopoietic stem cell transplantation for patients with advanced multiple myeloma [PDF]

, 2000
Bamberg, M., Budach, W., Einsele, H., Emmerich, B., Straka, C.   +4 more
core   +1 more source

The Art of Deception: Multiple Myeloma Imitating Spondyloarthritis-A Case Report. [PDF]

Clin Case Rep
Khatri P, Subedi A, Dahal B, Shrestha G, Phuyal M, Adhikari R.   +5 more
europepmc   +1 more source

Daratumumab, Bortezomib, and Dexamethasone for Multiple Myeloma.

New England Journal of Medicine, 2016
A. Palumbo, A. Chanan-Khan, K. Weisel, A. Nooka, T. Masszi, M. Beksaç, I. Špička, V. Hungria, M. Munder, M. Mateos, T. Mark, M. Qi, J. Schecter, H. Amin, X. Qin, W. Deraedt, T. Ahmadi, A. Spencer, P. Sonneveld   +18 more
semanticscholar   +1 more source

Circulating tumour cells (CTCs) in haematological malignancies: Advances in biology and clinical relevance with a focus on multiple myeloma

British Journal of Haematology, EarlyView.
Spatial heterogeneity limits the sensitivity of bone marrow biopsies, resulting in false‐negative findings. Circulating tumour cells (CTCs) provide a systemic, stratified monitoring approach, using flow cytometry for high tumour burden and EuroFlow or allele‐specific oligonucleotide PCR (ASO‐PCR) for minimal residual disease to enable early relapse ...
Chin‐Mu Hsu, Jui‐Feng Hsu, Jee‐Fu Huang, Yi‐Chang Liu   +3 more
wiley   +1 more source

Advances in the pathophysiology and treatment of anaemia in multiple myeloma. [PDF]

Curr Opin Hematol
Giuliani N, Dalla Palma B, Notarfranchi L.   +2 more
europepmc   +1 more source

Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group.

Journal of Clinical Oncology, 2015
A. Palumbo, H. Avet-Loiseau, S. Oliva, H. Lokhorst, H. Goldschmidt, L. Rosiñol, P. Richardson, S. Caltagirone, J. Lahuerta, T. Facon, S. Bringhen, F. Gay, M. Attal, R. Passera, A. Spencer, M. Offidani, Shaji K. Kumar, P. Musto, S. Lonial, Maria Teresa Petrucci, R. Orlowski, E. Zamagni, G. Morgan, M. Dimopoulos, B. Durie, K. Anderson, P. Sonneveld, J. S. San Miguel, M. Cavo, S. Rajkumar, P. Moreau   +30 more
semanticscholar   +1 more source